Sridhar Kosaraju Nevro Corp (NVRO) insider trading activity

Sridhar Kosaraju is of NEVRO CORP. Currently has a direct ownership of 39,525 shares of NVRO, which is worth approximately $229,245. The most recent transaction as insider was on Jun 30, 2024, when has been sold 1,870 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39.5K

4.97% 3M change

149.43% 12M change

Total Value Held $229,245

Sridhar Kosaraju Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 30 2024	BUY Grant, award, or other acquisition	-	1,870 Added 4.52%	39,525 Common Stock
May 23 2024	BUY Grant, award, or other acquisition	-	19,169 Added 33.73%	37,655 Common Stock
Mar 31 2024	BUY Grant, award, or other acquisition	-	1,090 Added 5.57%	18,486 Common Stock
Dec 31 2023	BUY Grant, award, or other acquisition	-	731 Added 4.03%	17,396 Common Stock
Sep 30 2023	BUY Grant, award, or other acquisition	-	819 Added 4.68%	16,665 Common Stock
Jun 30 2023	BUY Grant, award, or other acquisition	-	619 Added 3.76%	15,846 Common Stock
May 25 2023	BUY Grant, award, or other acquisition	-	6,754 Added 30.73%	15,227 Common Stock
Mar 31 2023	BUY Grant, award, or other acquisition	-	435 Added 4.88%	8,473 Common Stock
Dec 30 2022	BUY Grant, award, or other acquisition	-	397 Added 4.71%	8,038 Common Stock
Sep 30 2022	BUY Grant, award, or other acquisition	-	337 Added 4.22%	7,641 Common Stock
Jun 30 2022	BUY Grant, award, or other acquisition	-	331 Added 4.34%	7,304 Common Stock
May 26 2022	BUY Grant, award, or other acquisition	-	4,155 Added 37.34%	6,973 Common Stock
Mar 31 2022	BUY Grant, award, or other acquisition	-	190 Added 6.32%	2,818 Common Stock
Dec 31 2021	BUY Grant, award, or other acquisition	-	169 Added 6.04%	2,628 Common Stock
Aug 31 2021	BUY Grant, award, or other acquisition	-	2,459 Added 50.0%	2,459 Common Stock

Also insider at

PEN

Penumbra Inc Healthcare

President

TXG

10x Genomics, Inc. Healthcare